** Stu's Views & M.S. News **: A comprehensive overview of the eight FDA-approved disease-modifying therapies used to slow MS activity (including the newly approved oral therapy, Gilenya), and initial findings on many of the experimental treatments in development for the treatment of MS

ABOUT this BLOG and How to use it

WELCOME to Stu's Views & MS News. A product of MS Views and News, a Not-for-Profit [501c3] organization. Founded in 2008, we provide educational Multiple Sclerosis information via live seminars and via the internet.

Key-Notes: Our live seminars average approx 60 people per educational program. Our blog is visited over 2900 times per week and our website is visited by thousands each month.

Register at our website to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in (90) Countries.

On this blog see our Directory, Archives, recent Blog Posts & so much more. Use the Blog Search box (enter a keyword). See our Facebook information AND Links to other MS Organizations & bloggers. Scroll through entire page, to find information that could EMPOWER You. At the Bottom of this page, see informational videos and some for fun.

Disclaimer: "Stu's Views & MS News" / 'MS Views and News' does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Thursday, October 28, 2010

A comprehensive overview of the eight FDA-approved disease-modifying therapies used to slow MS activity (including the newly approved oral therapy, Gilenya), and initial findings on many of the experimental treatments in development for the treatment of MS

Information provided by: Cherie C. Binns RN BS MSCN

From the MS Association of America's Motivator Summer/Fall 2010 issue

Based on the positive response to the "MS Research Updates" published from 2007 through 2009 in New England Journal of Medicine, this year's article incorporates new information about the eight approved disease-modifying therapies (DMTs), as well as numerous experimental drugs currently under investigation for the treatment of MS. Highlights and recent study results are provided for each drug. This is not a complete list and not all information is included. Initial findings should be considered as preliminary, as additional studies and/or evaluations may be needed.

CLICK HERE to read this very well written / complete article on what we ( the MS patients), need to know to be kept informed and up-to-date.

***********************************************************

"Providing You with 'MS Views and News', is what we do"

Keep Informed and up-to-date with information concerning

Multiple Sclerosis when registered at

the MS Views and News website.

****************************************************************

Disclaimer: 'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

. ****************************************************************

2 comments:

Cherie said...: I found this article to be one of the most complete and informative on not only currently approved therapies but a one stop reference to the new medications currently being considered by the FDA and those preparing to be presented for FDA approval.

Kudos to the MS Association of America for coming out with such a well written and usable resource!; October 28, 2010 10:06 AM
Spiny Tim said...: Yeah, Stuart, this is one-stop-info-shopping-- you are the MS maven. Thanks!; October 29, 2010 9:30 AM